Align Technology, Inc. (ALGN) compared with its closest peers (EW, ZBH, SOLV, BAX, PEN): P/E 27.5 vs industry 32.9. Peer set by Business model: Medical Devices / Life Science Tools; 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| Edwards Lifesciences Corporation (EW) | $51.79B | 40.0 |
| Zimmer Biomet Holdings, Inc. (ZBH) | $19.15B | 25.2 |
| Solventum Corporation (SOLV) | $15.35B | 10.7 |
| Baxter International Inc. (BAX) | $13.65B | -10.2 |
| Penumbra, Inc. (PEN) | $12.76B | 87.5 |
| Globus Medical, Inc. (GMED) | $11.51B | 21.5 |
| Glaukos Corporation (GKOS) | $10.89B | -34.4 |
| MSA Safety Incorporated (MSA) | $7.27B | 23.1 |
| Enovis Corporation (ENOV) | $1.51B | -1.3 |
| Cadre Holdings, Inc. (CDRE) | $1.45B | 55.0 |
| Stock P/E | 27.5 |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Medical Equipment) | 32.9 |
| vs Sector | 27.4% |
| vs Industry | -16.3% |
ALGN overview · ALGN earnings · ALGN financials · ALGN KPIs · ALGN investor relations · ALGN ownership · ALGN filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.